Amneal Pharmaceuticals, Inc. Is A Global Biopharmaceutical Company Based In Bridgewater, New Jersey, Founded In 2002. The Company Operates In Three Main Segments: Affordable Medicines, Specialty Pharmaceuticals, And Avkare. Amneal Is Dedicated To Making Healthcare Accessible Through A Wide Range Of Generic And Specialty Pharmaceuticals, Offering Over 280 Products Primarily In The U.S. Market.The Affordable Medicines Segment Includes Generic Injectables, Biosimilars, And Retail Generics, Catering To Cost-Sensitive Markets. Specialty Pharmaceuticals Focuses On Treatments For Central Nervous System And Endocrine Disorders, With Branded Drugs For Conditions Like Parkinson’S Disease. The Avkare Segment Supplies Pharmaceuticals To U.S. Federal Agencies, Retail Pharmacies, And Institutional Buyers, Including Military Healthcare Programs. Amneal Has A Strong Emphasis On Complex Generics, Biosimilars, And Branded Therapies, Supported By Advanced Manufacturing Capabilities And A Global Commercial Infrastructure. The Company Has Grown Through Strategic Mergers, Including Its Combination With Impax Laboratories, And Continues To Invest In Research And Development To Enhance Its Product Offerings And Expand Its Market Reach.
